---
$id: https://graph.org.ai/products/commodity/51142546
$type: Product
source: UNSPSC
code: "51142546"
title: "Bromocriptine mesilate or mesylate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromocriptine mesilate or mesylate

**UNSPSC Code**: 51142546
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFP983J3OD, chemically known as 2-bromo-alpha-ergocryptine, methanesulfonate but more generally known as bromocriptine mesilate, which bears US NIH Compound Identifier 31100. European Medicines Agency schedules Bromocriptine mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00878MIG. Most nations, for tariff and trade purposes, schedule bromocriptine mesylate under HS 29396900. As of Q4 2014, BROMOCRIPTINE MESYLATE remains US FDA's Preferred Term for this commodity. Bromocriptine mesylate bears US NLM identifiers UMLS ID C0546852 and NCI Concept Code C317. SMILES: CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6C7C(CCCC7[NH]C6BR)C5=C4)C)O.CS(=O)(=O)O.

